European Journal of Clinical Pharmacology

, Volume 66, Issue 12, pp 1257–1264 | Cite as

Adverse drug reactions in internal medicine units and associated risk factors

  • Juan Francisco Sánchez Muñoz-TorreroEmail author
  • Paloma Barquilla
  • Raul Velasco
  • Maria del Carmen Fernández Capitan
  • Nazaret Pacheco
  • Lucia Vicente
  • Jose Luis Chicón
  • Sara Trejo
  • Jose Zamorano
  • Alicia Lorenzo Hernandez
Pharmacoepidemiology and Prescription



This study was designed to assess the prevalence of adverse drug reactions (ADRs) in the internal medicine wards of two teaching Hospitals, identify the most common ADRs, the principal medications involved, and determine the risk factors implicated in the occurrence of such ADRs.


All admissions over 10 weeks were followed prospectively using an intensive drug surveillance method to identify ADRs. Clinical laboratory data, the drug prescribed, and ADRs were taken into consideration. Status of nutrition, liver and kidney function at admission, and ADR time were determined. In order to assess drug interactions a software package was used.


A total of 405 patients were evaluated, 126 patients (31%) had 128 ADRs, 122 ADRs occurred during hospitalization. Two ADR-related deaths were observed during the study. Reactions affecting the gastrointestinal tract, skin, and hematological system were among the most frequent ADRs. For ADRs observed during admission predictors of its occurrence in a multivariate regression model were: OR (95% CI); more than 12 days’ hospitalization: 2.11(1.27–3.47), any drug interaction: 9.33 (5.12–17) and acute change in estimated glomerular filtration rate over admission >20%: 2.46 (1.45–4.2). Worsening of renal function or drug interaction was observed in nine of the ten ADRs. Age, sex, nutrition, and number of drugs used were not related to ADRs.


A significant prevalence of ADRs was found among hospitalized patients. Duration of hospital admission, changes in renal status during hospitalization and drug interactions seem to be important risk factors for ADRs.


Adverse drug reactions Incidence Risk factors 


  1. 1.
    Kohn LT, Corrigan JM, Donaldson MS (eds) (2000) Institute of medicine. To err is human: building a safer health system. National Academies Press, Washington, DCGoogle Scholar
  2. 2.
    Pirmohamed M, Breckenridge AM, Kitteringham NR, Park BK (1998) Adverse drug reaction. BMJ 316:1295–1298PubMedGoogle Scholar
  3. 3.
    Davies EC, Green CF, Mottram DR, Pirmohamed M (2007) Adverse drug reactions in hospitals: a narrative review. Curr Drug Saf 2:79–87CrossRefPubMedGoogle Scholar
  4. 4.
    Trontell A (2004) Expecting the unexpected: drug safety, pharmacovigilance, and the prepared mind. N Engl J Med 351:1385–1387CrossRefPubMedGoogle Scholar
  5. 5.
    Talley RB, Laventurier MF (1975) Drug-induced illness. JAMA 229:1043–1048Google Scholar
  6. 6.
    Lagnaoui R, Moore N (2000) Adverse drug reactions in a department of systemic diseases-oriented internal medicine: prevalence, incidence, direct costs and avoidability. Eur J Clin Pharmacol 56:181–186CrossRefPubMedGoogle Scholar
  7. 7.
    McDonnell PJ, Jacobs MR (2002) Hospital admissions resulting from preventable adverse drug reactions. Ann Pharmacother 36:1331–1336CrossRefPubMedGoogle Scholar
  8. 8.
    Klein U, Klein M, Sturm H (1976) The frequency of adverse drug reactions as dependent upon age, sex and duration of hospitalization. Int J Clin Pharmacol Biopharm 13:187–195PubMedGoogle Scholar
  9. 9.
    Martin RM, Biswas PN, Freemantle SN (1998) Age and sex distribution of suspected adverse drug reactions to newly marketed drugs in general practice in England: analysis of 48 cohort studies. Br J Clin Pharmacol 46:505–511CrossRefPubMedGoogle Scholar
  10. 10.
    Zopf Y, Rabe C, Neubert A, Janson C, Brune K, Hahn EG, Dormann H (2009) Gender-based differences in drug prescription: relation to adverse drug reactions. Pharmacology 84:333–339CrossRefPubMedGoogle Scholar
  11. 11.
    Krähenbühl-Melcher A, Schlienger R, Lampert M, Haschke M, Drewe J, Krähenbühl S (2007) Drug-related problems in hospitals: a review of the recent literature. Drug Saf 30:379–407CrossRefPubMedGoogle Scholar
  12. 12.
    Schein JR (1998) Epidemiology, outcomes research, and drug interactions. Drug Metabol Drug Interact 14:147–158PubMedGoogle Scholar
  13. 13.
    Kuperman GJ, Bobb A, Payne TH (2007) Medication-related clinical decision support in computerized provider order entry systems: a review. J Am Med Inform Assoc 14:29–40CrossRefPubMedGoogle Scholar
  14. 14.
    Rawlins MD, Thompson JW (1991) Mechanisms of adverse drug reactions. In: Davies DM (ed) Textbook of adverse drug reactions. Oxford University Press, Oxford, pp 18–45Google Scholar
  15. 15.
    Naranjo CA, Busto U, Sellers EM et al (1981) A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 30:239–245CrossRefPubMedGoogle Scholar
  16. 16.
    Lexi-Comp (2010) Drug interactions handbook, and drug interactions software. Accessed June 2010)
  17. 17.
    Hazell L, Shakir SA (2006) Under-reporting of adverse drug reactions: a systematic review. Drug Saf 29:385–396CrossRefPubMedGoogle Scholar
  18. 18.
    Pomeranz LJ, Corey PN BH (1998) A meta-analysis of prospective studies incidence of adverse drug reactions in hospitalized. JAMA 279:1200–1205CrossRefPubMedGoogle Scholar
  19. 19.
    Brvar M, Fokter N, Bunc M, Mozina M (2009) The frequency of adverse drug reaction related admissions according to method of detection, admission urgency and medical department specialty. BMC Clin Pharmacol 9:8CrossRefPubMedGoogle Scholar
  20. 20.
    Zopf Y, Rabe C, Neubert A, Hahn EG, Dormann H (2008) Risk factors associated with adverse drug reactions following hospital admission: a prospective analysis of 907 patients in two German university hospitals. Drug Saf 31:789–798CrossRefPubMedGoogle Scholar
  21. 21.
    Camargo AL, Cardoso Ferreira MB, Heineck I (2006) Adverse drug reactions: a cohort study in internal medicine units at a university hospital. Eur J Clin Pharmacol 62:143–149CrossRefPubMedGoogle Scholar
  22. 22.
    Fattinger K, Roos M, Vergères P (2000) Epidemiology of drug exposure and adverse drug reactions in two Swiss departments of internal medicine. Br J Clin Pharmacol 49:158–167CrossRefPubMedGoogle Scholar
  23. 23.
    Bond CA, Raehl CL (2006) Adverse drug reactions in United States hospitals. Pharmacotherapy 26:601–608CrossRefPubMedGoogle Scholar
  24. 24.
    Bates DW, Cullen DJ, Laird N et al (1995) Incidence of adverse drug events and potential drug events. Implications for prevention. JAMA 274:29–34CrossRefPubMedGoogle Scholar
  25. 25.
    Flockhart DA (1995) Drug interactions and cytochrome P450 system: the role of cytochrome P450 2C19. Clin Pharmacokinet 29 [Suppl 1]:45–52CrossRefPubMedGoogle Scholar
  26. 26.
    Szekendi MK, Sullivan C, Bobb A et al (2006) Active surveillance using electronic triggers to detect adverse events in hospitalized patients. Qual Saf Health Care 15:184–190CrossRefPubMedGoogle Scholar
  27. 27.
    Bobb A, Gleason K, Husch M (2004) The epidemiology of prescribing errors: the potential impact of computerized prescriber order entry. Arch Intern Med 164:785–792CrossRefPubMedGoogle Scholar
  28. 28.
    Helldén A, Bergman U, von Euler M (2009) Adverse drug reactions and impaired renal function in elderly patients admitted to the emergency department: a retrospective study. Drugs Aging 26:595–606CrossRefPubMedGoogle Scholar
  29. 29.
    Verbeeck RK, Musuamba FT (2009) Pharmacokinetics and dosage adjustment in patients with renal dysfunction. Eur J Clin Pharmacol 65:757–773CrossRefPubMedGoogle Scholar
  30. 30.
    Lundkvist J, Jönsson B (2004) Pharmacoeconomics of adverse drug reactions. Fundam Clin Pharmacol 18:275–280CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag 2010

Authors and Affiliations

  • Juan Francisco Sánchez Muñoz-Torrero
    • 1
    Email author
  • Paloma Barquilla
    • 1
  • Raul Velasco
    • 1
  • Maria del Carmen Fernández Capitan
    • 2
  • Nazaret Pacheco
    • 1
  • Lucia Vicente
    • 1
  • Jose Luis Chicón
    • 1
  • Sara Trejo
    • 1
  • Jose Zamorano
    • 1
  • Alicia Lorenzo Hernandez
    • 2
  1. 1.Servicio de Medicina InternaHospital San Pedro de AlcantaraCáceresSpain
  2. 2.Hospital La PazMadridSpain

Personalised recommendations